IBB News 256.47 10/16/2014 05:11:08 Nasdaq Biotechnology Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 256.47 $IBB

IBB, GULF, GDP, DBOEY, Added To Naked Short Lists Today
M2 - Mon Oct 13, 10:51AM CDT
BUYINS.NET, www.buyins.net , announced today that these select companies have been Added To the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. Ishares Nasdaq Biotechnology (NASDAQ:IBB), WisdomTree Middle East Dividend Fund (NASDAQ:GULF), Goodrich Petroleum Corp (NYSE:GDP), Deutsche Boerse AG (OTC BOEY). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .
GDP: 9.48 (+1.38), GULF: 22.00 (-1.45), IBB: 256.47 (+1.20)

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 2.09%
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 256.47 (+1.20)

After Yesterday's Decline of 2.09%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Fri Oct 10, 4:47PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $262.08 to a high of $271.25. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $264.52 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 256.47 (+1.20)

'Fast Money' Recap: Relief About the Stock Market Rally
at The Street - Thu Oct 09, 4:00AM CDT
The trading panel discussed where they are putting their money after the change in market direction.
F: 13.62 (-0.16), LMT: 175.19 (-0.92), ARWR: 6.47 (+0.59), XOP: 56.65 (+2.26), XBI: 152.22 (+5.15), C: 49.68 (-1.79), M: 56.00 (-0.58), IBB: 256.47 (+1.20), SHLD: 29.56 (+1.07), AA: 14.50 (+0.21), TJX: 60.10 (-1.31), RIG: 29.44 (+0.47), GILD: 96.16 (-1.02), GLD: 118.99 (+0.40), TGT: 59.98 (-1.71), JCP: 7.09 (-0.07), GM: 29.69 (-0.42), GOOGL: 540.73 (-7.96), GPS: 35.94 (-0.51), TWTR: 49.99 (+1.41), XLE: 80.56 (+0.61)

'Fast Money' Recap: What Should You Buy in a Declining Market?
at The Street - Wed Oct 08, 4:00AM CDT
The trading panel discusses Yum! Brands, the mining industry and Ebola treatments.
PEI: 19.15 (-0.09), CLR: 53.85 (+1.11), GMCR: 139.61 (+0.96), TKMR: 23.90 (+0.30), IBB: 256.47 (+1.20), M: 56.00 (-0.58), JBLU: 10.30 (+0.07), UPS: 96.45 (+0.65), PEP: 91.77 (-1.24), SBUX: 72.38 (-0.36), AGN: 177.59 (-4.40), SAVE: 53.97 (-1.40), CMRX: 32.18 (+3.13), EOG: 88.17 (+4.33), DPZ: 83.65 (-0.65), COST: 124.30 (-1.95), GOOGL: 540.73 (-7.96), CMLS: 3.29 (+0.12), AAPL: 97.54 (-1.21), MBLY: 45.35 (+0.72), YUM: 67.23 (-0.59), APC: 85.46 (+0.80), AMBA: 38.60 (+2.94), AEC: 18.61 (+0.06), GPRO: 72.87 (-2.16), ETN: 58.97 (-0.08), IR: 53.94 (-0.14), GSK: 43.13 (-0.55), PXD: 171.58 (+6.80), MCD: 90.44 (-0.66), GM: 29.69 (-0.42), IWM: 106.60 (+1.06), SODA: 21.21 (+0.26)

Why Is George Soros Buying Celgene Corporation?
George Budwell, The Motley Fool - Motley Fool - Mon Oct 06, 9:01AM CDT
Superinvestors have transcended the investing landscape for one simple reason: they are awfully good at making money. Many smaller investors therefore like to track the movements of these "elephants" to see what they are buying and selling in hopes...
IBB: 256.47 (+1.20), CELG: 86.55 (+0.07)

The Complete Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Oct 02, 11:09AM CDT
Biotech sector appears to be back on track with fundamentals remaining attractive.
PBE: 44.23 (+0.60), FBT: 87.34 (+0.43), XBI: 152.22 (+5.15), BBH: 98.14 (+0.57), IBB: 256.47 (+1.20)

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 1.50% Loss
Comtex SmarTrend(R) - Wed Oct 01, 4:11PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $267.58 to a high of $273.65. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $272.22 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 256.47 (+1.20)

'Fast Money' Recap: How to Trade After the Market's Drop
at The Street - Fri Sep 26, 4:00AM CDT
The trading panel likes the idea of buying Microsoft, Intel and other tech stocks if the market opens lower Friday
BIIB: 305.69 (+4.11), NKE: 85.18 (+0.09), XBI: 152.22 (+5.15), BBRY: 9.11 (+0.21), IBB: 256.47 (+1.20), INTC: 31.27 (-0.87), YHOO: 37.82 (-0.15), DD: 66.43 (+0.55), GOOGL: 540.73 (-7.96), MSFT: 43.22 (-0.51), AAPL: 97.54 (-1.21), REGN: 334.75 (+6.68), AMZN: 305.97 (-2.34), MU: 27.54 (+0.15), VRTX: 101.10 (-3.16), EMN: 73.47 (+0.65), FB: 73.21 (-0.38), BRCM: 35.46 (+0.05), PFE: 28.19 (-0.27), AMGN: 130.90 (-1.30), TIF: 87.77 (-1.09), HPQ: 32.80 (+0.56), PCLN: 1,058.75 (+8.30), LULU: 39.60 (+0.16), MHR: 4.54 (+0.56), GILD: 96.16 (-1.02), FNV: 55.44 (+1.97), RGLD: 67.87 (+0.31), IWM: 106.60 (+1.06), DOW: 44.09 (+0.16), BABA: 85.60 (+0.65), AN: 48.00 (+0.28)

SmarTrend Watching for Potential Pullback in Shares of iShares Nasdaq Biotechnology Index After 2.80% Gain
Comtex SmarTrend(R) - Wed Sep 24, 3:51PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $272.71 to a high of $279.55. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $277.23 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IBB: 256.47 (+1.20)

BioShares Plans Two Innovative Biotech ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Wed Sep 24, 7:00AM CDT
BioShares is looking to launch some very unique biotechnology ETFs soon.
FBT: 87.34 (+0.43), XBI: 152.22 (+5.15), IBB: 256.47 (+1.20)

'Fast Money' Recap: How Alibaba Is Hitting Momentum Stocks
at The Street - Tue Sep 16, 4:00AM CDT
The trading panel discussed Chinese stocks, Apple's new phone and whether Darden shares are worth buying.
TSLA: 229.70 (+2.64), XBI: 152.22 (+5.15), IBB: 256.47 (+1.20), JBLU: 10.30 (+0.07), DEO: 109.77 (-0.09), NOK: 7.77 (-0.19), YHOO: 37.82 (-0.15), EBAY: 50.24 (-0.35), PLCE: 48.03 (-0.18), TWTR: 49.99 (+1.41), MSFT: 43.22 (-0.51), AAPL: 97.54 (-1.21), REGN: 334.75 (+6.68), AMZN: 305.97 (-2.34), ABX: 13.55 (-0.12), NADL: 5.54 (-0.31), DRI: 48.24 (+0.11), CELG: 86.55 (+0.07), AA: 14.50 (+0.21), BIDU: 205.73 (+6.66), TSO: 58.64 (-0.58), GILD: 96.16 (-1.02), ACHN: 10.13 (+0.12), IWM: 106.60 (+1.06), BF.B: 83.61 (-1.04), CRM: 53.09 (+0.37)

iShares Nasdaq Biotechnology Index Falls 1.26% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Sep 15, 3:57PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $263.64 to a high of $268.99. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $268.24 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IBB: 256.47 (+1.20)

3 Reasons Actavis plc Stock Could Fall
George Budwell, The Motley Fool - Motley Fool - Mon Sep 15, 10:50AM CDT
Healthcare and biotechnology stocks have put on another amazing show this year, with the closely watched  iShares Nasdaq Biotechnology Index   pushing higher by nearly 19% so far. And certain subsectors, including generic and specialty...
ACT: 217.24 (-4.83), IBB: 256.47 (+1.20), TEVA: 50.09 (+0.19)

WIT, IBB, EROC, MPX, SEP, TUZ Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Sep 15, 4:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Wipro Ltd (NYSE:WIT), Ishares Nasdaq Biotechnology (NASDAQ:IBB), EAGLE ROCK ENERGY PARTNERS (NASDAQ:EROC), Marine Products Corp (NYSE:MPX), Spectra Energy Partners LP (NYSE:SEP), PimCo 1 3 Year Us Treasury Index Fund (NYSE:TUZ) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
MPX: 7.89 (+0.02), WIT: 12.22 (+0.02), TUZ: 51.17 (+0.07), SEP: 49.65 (+0.17), IBB: 256.47 (+1.20), EROC: 2.77 (-0.09)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 84

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
Five Films Put Modern Infrastructure Under a Lens

Updated Category News Views 77

Most infrastructure only earns a thought when it breaks, and that is precisely the nerve these films are trying to touch. Nicely Done Productions has released the final five installments of its ten-part Threads of Connectivity documentary series, hosted on National Geographic's global digital platform. The subjects are illycaffè, Cargill, Honeywell Aerospace, Western...

Continue Reading
Colon Cleanse Advice Deserves a Careful Read First

Updated Category News Views 59

Wellness copy can sound harmless right up until it blurs comfort guidance with health guidance. HelloNation’s feature on what to expect after a colon cleanse, drawing on Suzanne Childre of Gentle Wellness Center in Santa Monica, lays out a fairly familiar recovery script: drink water, rest, eat lightly, expect some bowel changes, and do not panic over a little fatigue....

Continue Reading
Visa CEDP Data Gaps Are Quietly Hammering Merchants

Updated Category News Views 56

Somewhere between a checkout button and settlement, an awful lot of money is apparently falling through a trapdoor. Verisave and Canyon Payments say 93% of the 180 merchant accounts they reviewed during one month missed Visa Commercial Enhanced Data Program discounts they could have received. The claimed savings left on the table topped $800,000 for that group in that...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 60

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 146

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading
AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 140

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
RAN Rebound Gains Speed, but 2027 Still Looks Flat

Updated Category News Views 101

Radio gear finally caught a pulse in the third quarter, and that matters after more than two years of contraction. Dell’Oro Group says worldwide Radio Access Network revenue rose at a mid-single-digit year-over-year rate in 3Q 2026, the market’s strongest quarterly growth in nearly five years. That is better than expected, which is a welcome change in a telecom...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 104

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Elanco’s $600 Million Buyback Signals a New Chapter

Updated Category News Views 84

Debt coming down and cash coming in finally gave Elanco room to breathe. On Nov. 19, 2026, the animal-health company authorized its first-ever share repurchase program, allowing up to $600 million of common-stock purchases. For NYSE: ELAN, this is more than a flashy capital-return headline. It marks a shift from the ugly but necessary job of balance-sheet repair toward a...

Continue Reading

Top 5 Most Recently Viewed Articles

Bret Baier's Exclusive Interview with Trump on FOX Super Bowl Show

Updated Category News Views 296

Bret Baier's Exclusive Interview with President Donald Trump In a highly anticipated television event, Bret Baier, the chief political anchor for FOX News Channel (FNC), will engage in a significant one-on-one interview with President Donald Trump during the FOX Super Bowl LIX pregame show. This exclusive interview will air in the 3 PM/ET hour and is set to be a revealing...

Continue Reading
3D Systems Corporation Lawsuit Notification: What Investors Should Know

Updated Category News Views 169

3D Systems Corporation Lawsuit Overview The Gross Law Firm has issued a notice regarding an important class action lawsuit that involves shareholders of 3D Systems Corporation (NASDAQ: DDD). This legal action arises from allegations concerning misleading statements made by the company during a specific class period that could affect investors significantly. Understanding...

Continue Reading
5W PR Takes Charge of Marketing Strategies for Bedsure Pet

Updated Category News Views 191

5W PR Appointed as Agency of Record for Bedsure Pet Bedsure Pet, a leader in pet essentials, has recently welcomed 5W PR as their Agency of Record. This collaboration aims to elevate the brand's visibility and credibility in the competitive pet products market. About Bedsure Pet Products Bedsure Pet is celebrated for offering a wide range of high-quality pet products,...

Continue Reading
Itafos Enhances Financial Stability by Selling St George Shares

Updated Category News Views 155

Itafos Strengthens Financial Position Through Share Monetization HOUSTON, Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) has made headlines with its recent strategic move to partially monetize its equity interest in St George Mining Limited. This transaction, framed within the context of a larger corporate strategy, was initially announced following the sale of the Araxá...

Continue Reading
Hawkeye Invest AS Expands Stake in PCI Biotech Holding ASA

Updated Category News Views 343

Hawkeye Invest AS Enhances its Investment in PCI Biotech Holding ASA In a significant move, Hawkeye Invest AS, under the leadership of Øystein Barmen, has increased its stake in PCI Biotech Holding ASA by acquiring an additional 240,000 shares. This latest purchase has elevated their total ownership to 2,000,000 shares, representing a noteworthy 5.36% of the total shares...

Continue Reading